Company news
ASKA Pharmaceutical Holdings Co., Ltd. news in 2026
ASKA Pharmaceutical Holdings Co., Ltd.'s news releases, calls and decks from 2026, newest first.
ASKA Pharmaceutical Enters into License Agreement for MHB018A for the Treatment of Thyroid Eye Disease (TED)
November 4, 2026
Supplementary Documents of Consolidated Financial Results for the Second Quarter of FY2026
November 4, 2026
Summary of Financial Results for the First Half (Interim Period) of the Fiscal Year Ending March 31, 2027 (Japanese GAAP) (Consolidated)
November 4, 2026
Completion of Payment for Disposal of Treasury Shares as Restricted Stock Incentives for the Employee Stock Ownership Association and Partial Forfeit
November 2, 2026
Notice Concerning Completion of Payment for Disposal of Treasury Shares as Remuneration for Restricted Shares
August 12, 2026
Summary of Consolidated Financial Results for the First Quarter of FY2026
August 4, 2026
Notice Concerning Disposal of Treasury Shares as Remuneration for Restricted Stock
July 13, 2026
Notice Regarding Results of the 5th Ordinary General Meeting of Shareholders
June 25, 2026